Poddar Pigments Q1 FY27: PAT +11.6% YoY (standalone), core margin compresses on OI surge

Poddar Pigments' standalone Q1 FY27 revenue from operations was ₹90.13 Cr, down 1.2% YoY from ₹91.26 Cr and down 10.3% QoQ from the seasonally stronger ₹100.45 Cr in Q4 FY26. Standalone PAT came in at ₹4.65 Cr, up 11.6% YoY from ₹4.17 Cr, but nearly flat QoQ (-2.0% vs ₹4.74 Cr). The YoY profit growth, however, is almost entirely a function of other income rather than the core business: other income jumped 136.8% YoY to ₹4.90 Cr (from ₹2.07 Cr) and 35.8% QoQ, while core operating profit (EBITDA excluding other income) fell 19.0% YoY to ₹5.36 Cr from ₹6.62 Cr. The resulting margin split is telling — NPM expanded to 5.16% from 4.46% YoY on the other-income lift, while the OPM/EBITDA margin compressed to 5.95% from 7.25% YoY (though it did recover from Q4 FY26's 4.25% low). PBT rose 15.6% YoY to ₹7.17 Cr; the tax outgo was ₹2.52 Cr (35.2% effective rate, split ₹1.02 Cr current + ₹1.50 Cr deferred), against ₹2.03 Cr a year ago. EPS was ₹4.38, up from ₹3.93 YoY and down marginally from ₹4.47 QoQ. We have no prior management guidance or concall commentary on record for this company, and a web search turned up no analyst previews or consensus estimates for this quarter — Poddar Pigments does not appear to carry regular sell-side coverage, so vsStreet and vsGuidance are both unknown rather than a miss. No management press release accompanied this filing beyond the standard board-outcome letter and auditor's limited review report. The only other corporate action in the window is procedural: the board fixed the 35th AGM for September 21, 2026, following the 40% final FY26 dividend recommended at the May 15, 2026 board meeting — neither bears on this quarter's operating numbers. No exceptional or extraordinary items were reported in either the current or year-ago quarter, so the YoY PAT growth is on a like-for-like basis, even as the underlying revenue/EBITDA trend was soft.